orthopedics

Histogen Inc (NASDAQ: HSTO) has decided to suspend the development of the HST 001 program after taking into consideration the results from the Phase 1b/2a trial in androgenic alopecia (male pattern baldness). It said while HST 001 demonstrated a favorable safety and tolerability...

Medical technology and orthopedic implant company Stryker Corporation (NYSE: SYK) reported an earnings beat Tuesday, and three sell-side analysts remain bullish on the stock. Stryker reported quarterly earnings of $1.88 per share, beating the consensus estimate of $1.84 and up about 12...

Medical technology company Stryker Corporation (NYSE: SYK) came out with better than expected second-quarter numbers on Thursday post market closing. The company also raised its 2015 sales growth guidance to 6.5–7.5 percent from 6–7 percent earlier. Kevin Lobo, Stryker chairman and...